These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

656 related items for PubMed ID: 24447596

  • 1. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M, Martínez P, Corrales A, Fandos N, García S, Insua D, Montañes M, Pérez-Grijalba V, Rueda N, Vidal V, Martínez-Cué C, Pesini P, Sarasa M.
    Neuroscience; 2014 Mar 28; 263():269-79. PubMed ID: 24447596
    [Abstract] [Full Text] [Related]

  • 2. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z.
    Behav Brain Res; 2011 Sep 23; 222(2):342-50. PubMed ID: 21513747
    [Abstract] [Full Text] [Related]

  • 3. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, Price DL, Tang F, Markowska AL, Borchelt DR.
    Neurobiol Dis; 2005 Apr 23; 18(3):602-17. PubMed ID: 15755686
    [Abstract] [Full Text] [Related]

  • 4. Progressive Spatial Memory Impairment, Brain Amyloid Deposition and Changes in Serum Amyloid Levels as a Function of Age in APPswe/PS1dE9 Mice.
    Fu L, Sun Y, Guo Y, Yu B, Zhang H, Wu J, Yu X, Wu H, Kong W.
    Curr Alzheimer Res; 2018 Apr 23; 15(11):1053-1061. PubMed ID: 29984654
    [Abstract] [Full Text] [Related]

  • 5. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
    Edwards SR, Hamlin AS, Marks N, Coulson EJ, Smith MT.
    Clin Exp Pharmacol Physiol; 2014 Oct 23; 41(10):798-806. PubMed ID: 25115283
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: involvement of oxidative stress and cholinergic dysfunction.
    Zhang W, Bai M, Xi Y, Hao J, Liu L, Mao N, Su C, Miao J, Li Z.
    Free Radic Biol Med; 2012 Apr 15; 52(8):1443-52. PubMed ID: 22342520
    [Abstract] [Full Text] [Related]

  • 9. Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    O'Leary TP, Brown RE.
    Behav Brain Res; 2009 Jul 19; 201(1):120-7. PubMed ID: 19428625
    [Abstract] [Full Text] [Related]

  • 10. Impairments of long-term depression induction and motor coordination precede Aβ accumulation in the cerebellum of APPswe/PS1dE9 double transgenic mice.
    Kuwabara Y, Ishizeki M, Watamura N, Toba J, Yoshii A, Inoue T, Ohshima T.
    J Neurochem; 2014 Aug 19; 130(3):432-43. PubMed ID: 24684630
    [Abstract] [Full Text] [Related]

  • 11. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
    Ribeiro CA, Oliveira SM, Guido LF, Magalhães A, Valencia G, Arsequell G, Saraiva MJ, Cardoso I.
    J Alzheimers Dis; 2014 Aug 19; 39(2):357-70. PubMed ID: 24169237
    [Abstract] [Full Text] [Related]

  • 12. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W, Zhang W, Li Z, Hao J, Zhang Z, Liu L, Mao N, Miao J, Zhang L.
    Pharmacol Biochem Behav; 2012 Jan 19; 100(3):361-9. PubMed ID: 21993310
    [Abstract] [Full Text] [Related]

  • 13. Enoxaparin treatment administered at both early and late stages of amyloid β deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Aβ levels.
    Timmer NM, van Dijk L, van der Zee CE, Kiliaan A, de Waal RM, Verbeek MM.
    Neurobiol Dis; 2010 Oct 19; 40(1):340-7. PubMed ID: 20600909
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease.
    Xiong H, Callaghan D, Wodzinska J, Xu J, Premyslova M, Liu QY, Connelly J, Zhang W.
    Neurosci Bull; 2011 Aug 19; 27(4):221-32. PubMed ID: 21788993
    [Abstract] [Full Text] [Related]

  • 16. The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.
    Wang D, Liu X, Liu Y, Li S, Wang C.
    J Alzheimers Dis; 2017 Aug 19; 59(4):1255-1267. PubMed ID: 28731433
    [Abstract] [Full Text] [Related]

  • 17. Multiple inflammatory pathways are involved in the development and progression of cognitive deficits in APPswe/PS1dE9 mice.
    Zhang W, Bai M, Xi Y, Hao J, Zhang Z, Su C, Lei G, Miao J, Li Z.
    Neurobiol Aging; 2012 Nov 19; 33(11):2661-77. PubMed ID: 22277264
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
    Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, Prada C, Greenberg SM, Bacskai BJ, Frosch MP.
    Neurobiol Dis; 2006 Dec 19; 24(3):516-24. PubMed ID: 17029828
    [Abstract] [Full Text] [Related]

  • 20. [Fundamental study of memory impairment and non-cognitive behavioral alterations in APPswe/PS1dE9 mice].
    Taniuchi N, Niidome T, Sugimoto H.
    Yakugaku Zasshi; 2015 Dec 19; 135(2):323-9. PubMed ID: 25747232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.